Vistagen Therapeutics, Inc.
VTGN· Nasdaq
VTGNVistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc.’s Q2 2027 10-Q window runs Nov 4, 2026 to Nov 16, 2026.
Based on 8 prior 10-Q filings.
Vistagen Therapeutics, Inc. · CIK 1411685 · Engraved from SEC EDGAR
